By Dan Darrow
November 14, 2022
Intraday Update: BIIB
Competitor Alzheimer's data from Roche this morning was a disappointment, sending BIIB up sharply to start the week. BIIB is trading around 300 early, marking its best intraday level since September 2021. The Dec16 $295 - $305 call spread roll-up is solidly into the money, so the plan will be to lock in the remainder of the trade and watch for a pause/consolidation to possibly revisit another bullish strategy into the upcoming CTAD conference.
Trader Author Portfolio Holdings
**As of the date and time of publication